Robuta

https://www.thepharmaletter.com/biotech-news/medicines-australia-welcomes-federal-court-s-decision-to-allow-patenting-of-genetic-materials Australia's federal court rules that companies can patent genetic material | Biotechnology | The... Australia’s Federal Court decision to allow patenting of genetic materials is good news for intellectual property laws in drug development, says Brendan Shaw, t federal courtgenetic materialaustraliarulescompanies https://nationalaglawcenter.org/publication/note-the-beans-of-wrath-genetic-patent-holders-reap-further-protection-monsanto-co-v-bowman-657-f-3d-1341-2011-19-j-environmental-sustainability-l-426-450-2013/ Note, The Beans of Wrath: Genetic Patent Holders Reap Further Protection (Monsanto Co. v. Bowman,... genetic patentnotebeanswrathholders https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2024.1425529/full Frontiers | Therapeutic applications of synthetic gene/genetic circuits: a patent review A significant limitation of numerous current genetic engineering therapy approaches is their limited control over the strength, timing, or cellular context o... synthetic genefrontierstherapeuticapplicationsgenetic https://www.acmgeducation.net/Public/Catalog/Details.aspx?id=hLafZeA622lad37B42ZMjA%3D%3D Aug 18 - From Lab to Clinic: What Restoring Patent Eligibility for Genetic Material Means for the... patent eligibilitygenetic materialauglabclinic